GPR108 Activators
GPR108 Activators encompass a series of chemical compounds that enhance the functional activity of GPR108 through distinct and specific signaling pathways. For instance, Forskolin, by stimulating adenylyl cyclase, leads to an accumulation of cAMP, which in turn activates PKA. This kinase can then phosphorylate various proteins that may include GPR108, enhancing its activity. Similarly, Ionomycin and A23187 act as calcium ionophores, increasing intracellular calcium levels, which is a crucial secondary messenger in many signaling cascades. The elevated calcium can activate pathways that potentially lead to the modification of GPR108's conformation or its interactions with other proteins, augmenting its activity. Isoproterenol, through its action on beta-adrenergic receptors, and BAY 60-6583, through the A2B adenosine receptor, also elevate cAMP and can activate downstream pathways that enhance GPR108's signaling. PMA, through PKC activation, and IBMX, by inhibiting cAMP breakdown, further contribute to theactivation of signaling pathways that engage GPR108.
Continuing with this theme, Rolipram and Nicotinamide riboside operate by increasing intracellular levels of cAMP and NAD+ respectively, both of which are significant modulators of cellular signaling. The resulting upsurge in cAMP from Rolipram's inhibition of PDE4, and the increase in NAD+-dependent processes due to Nicotinamide riboside, can enhance GPR108 signaling. L-NAME adds a different dimension by modulating nitric oxide (NO) levels, which in turn affects G-protein-coupled receptor functions including those related to GPR108. SKF-96365 contributes by altering calcium signaling, offering another route by which GPR108 activity could be enhanced through the downstream effects of modified calcium entry. Lastly, ZM 241385, although an antagonist of the adenosine A2A receptor, potentially induces compensatory changes in adenosine signaling that can lead to the indirect enhancement of GPR108 activity.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylyl cyclase, increasing levels of cAMP, which can lead to the activation of protein kinase A (PKA). PKA is known to phosphorylate various targets that could include GPR108, leading to its enhanced functional activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels. Elevated calcium can activate calcium-sensitive signaling cascades that potentially influence GPR108 activity by modifying the protein's conformation or interaction with other signaling proteins. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that activates cAMP production by stimulating adrenergic receptors. The resultant increase in cAMP may enhance GPR108 signaling through cAMP-dependent pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which is involved in numerous signaling pathways. PKC activation can lead to the phosphorylation of proteins related to GPR108 signaling, enhancing its functional activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
3-Isobutyl-1-methylxanthine (IBMX) is a non-selective inhibitor of phosphodiesterases, leading to increased cAMP levels by preventing its breakdown. Higher cAMP levels can indirectly promote GPR108 function through elevated PKA activity. | ||||||
BAY 60-6583 | 910487-58-0 | sc-503262 | 10 mg | $210.00 | ||
BAY 60-6583 selectively activates adenosine A2B receptors, which can lead to increased intracellular cAMP. This boost in cAMP may enhance GPR108 activity by engaging PKA and EPAC signaling pathways. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4 (PDE4), which breaks down cAMP. By inhibiting PDE4, rolipram increases cAMP levels, potentially leading to the activation of pathways that enhance GPR108 activity. | ||||||
L-NG-Nitroarginine Methyl Ester (L-NAME) | 51298-62-5 | sc-200333 sc-200333A sc-200333B | 1 g 5 g 25 g | $48.00 $107.00 $328.00 | 45 | |
N^G-Nitro L-arginine methyl ester (L-NAME) is an inhibitor of nitric oxide synthase. By reducing NO production, it can influence GPR108 activity indirectly, as NO signaling can modulate numerous G-protein-coupled receptor functions. | ||||||
SK&F 96365 | 130495-35-1 | sc-201475 sc-201475B sc-201475A sc-201475C | 5 mg 10 mg 25 mg 50 mg | $103.00 $158.00 $397.00 $656.00 | 2 | |
SKF-96365 inhibits receptor-mediated calcium entry, which may lead to alterations in calcium signaling pathways. These changes can indirectly influence GPR108 activity by modulating downstream targets that interact with GPR108. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is another calcium ionophore that increases intracellular calcium levels, similar to Ionomycin. The elevated calcium can activate signaling pathways that potentially enhance the activity of GPR108. | ||||||